Chief Scientific Officer · C4 Therapeutics, Inc. (CCCC)

Stewart Fisher

A named executive officer of C4 Therapeutics in every fiscal year CompBrief holds from FY2019 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$1,533,917

Salary $479,232Stock awards $147,420

FY2022: $3,104,878

3rd of 3 named executive officers at C4 Therapeutics by FY2023 total.

3 named officers on file for C4 Therapeutics, FY2023

Stewart Fisher’s pay file — $29

  • 5 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing
  • CCCC’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how C4 Therapeutics’s whole pay program stands against its peers

  • C4 Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on CCCC→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2024 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Stewart Fisher’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Stewart Fisher compensation by year

C4 Therapeutics Summary Compensation Table · all 5 fiscal years held
In US dollars, as C4 Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020FY2021FY2022FY2023
Salary$340,313$379,663$434,700$460,800$479,232
Bonus$0$54,000$54,000$0$0
Stock awards$0$0$0$558,698$147,420
Option awards$0$963,530$3,094,174$1,888,838$711,925
Non-equity incentive$119,110$186,500$200,000$184,320$182,020
Pension and deferred compensation$0$0$0$0$0
All other$6,330$6,000$6,000$12,222$13,320
Total$465,753$1,589,693$3,788,874$3,104,878$1,533,917

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: C4 Therapeutics, Inc. DEF 14A filed April 29, 2024, accession 0001628280-24-018785, and prior-year filings. Open the filing on EDGAR.

How this page was built: the C4 Therapeutics, Inc. filed document, accession 0001628280-24-018785. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2024.

$466K
$1.6M
$3.8M
$3.1M
$1.5M
FY19
FY20
FY21
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU26,000$146,900—
PSU16,500$75,056—
Option120,000—$2.15
Option101,563—$5.67
Option29,672—$45.54
Option66,375—$22.71
Option61,320—$4.98
Option22,224—$4.98

Per the Outstanding Equity Awards at Fiscal Year-End table in C4 Therapeutics, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

3 Form 4 lines since the FY2023 proxy (filed April 29, 2024)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2024-09-16Exercise or conversion—2,250—131,371
2024-09-16Tax withholding—661$6.36130,710
2024-09-16Exercise or conversion derivative—2,250$0.0014,250

The 3 most recent of 3 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

C4 Therapeutics’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
Andrew HirschPresident & Chief Executive Officer$3,790,099
Leonard ReynoChief Medical Officer$1,674,727
Stewart Fisher · this pageChief Scientific Officer$1,533,917

The full C4 Therapeutics compensation record

free company brief

This page is one person within C4 Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the C4 Therapeutics proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are C4 Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Stewart Fisher's compensation dossier · One-time report. No refunds.